Publications found:
50,761
Sort by:
2012 U.S. Input & Output Outlook
US$ 199.00
The 2012 U.S. Input & Output Outlook report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2012 current es...
July 2012
264 pages
Cempra: “GAIN from Drugs for Bad Bugs”
US$ 140.00
Drug resistance is a growing concern worldwide and Cempra (CEMP) is one of our lead recommendations ... offer an attractive investment opportunity in this therapy class. CEMP’s lead drug, 1. Solithromycin (CEM-101, PhIII, CABP; PhII cUTI) ... released on 2nd July, 2012 on CEMP titled “GAIN from Drugs for Bad Bugs”
July 2012
9 pages
US Cardiac Device Market Analysis
US$ 1,000.00
The higher prevalence of cardiovascular diseases has become a cause of concern for the US healthcare authorities as mortalities tend to rise and economic burden keep increasing. It is estimated that t...
July 2012
75 pages
US Clinical Laboratory Testing Market Assessment
US$ 1,000.00
The US represents an attractive destination for healthcare services’ market segments, especially clinical lab testing, which has evolved as a major source of decisive factor for healthcare professiona...
July 2012
45 pages
Onyx Pharma – Kyprolis to Accelerate Growth
US$ 140.00
... events – cardiovascular toxicities and deaths associated with Kyprolis as expected. ONXX has finally succeeded in ... Nexavar (L, RCC, HCC, partnered with Bayer), Kyprolis, and Regorafenib (R, oral multi-kinase inhibitor, GIST ... on Jun 21, 2012 on Onyx Pharma titled “Onyx Pharma - Kyprolis to Accelerate Growth”
June 2012
4 pages
